Nocera (NASDAQ: NCRA) investors back reverse split, 2B share authorization
Rhea-AI Filing Summary
Nocera, Inc. reported results of its 2025 annual stockholder meeting held virtually on January 12, 2026. As of the October 29, 2025 record date, 14,373,597 common shares were outstanding and entitled to vote, and 12,552,055 shares were represented, forming a quorum.
Stockholders elected five directors and ratified Enrome LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. They also approved, for Nasdaq Listing Rule 5635(d) purposes, potential issuances of common stock above 19.99% of outstanding shares upon conversion of Series B Convertible Non-Voting Preferred Stock and senior secured convertible notes, including at prices below the Nasdaq Minimum Price.
In addition, stockholders approved amendments to the Articles of Incorporation authorizing a reverse stock split of the issued and outstanding common stock at a ratio between 1-for-5 and 1-for-100, to be implemented at the Board’s discretion within the next year, and increasing authorized common shares from 200,000,000 to 2,000,000,000.
Positive
- None.
Negative
- Substantial increase in authorized shares and conversion approvals: Authorized common stock rose from 200,000,000 to 2,000,000,000, and stockholders approved potential issuances above 19.99% of outstanding shares upon conversion of Series B Convertible Non-Voting Preferred Stock and senior secured convertible notes at prices that may be below the Nasdaq Minimum Price, allowing significant potential dilution.
- Reverse stock split authorization with wide ratio range: Stockholders approved a reverse stock split of issued and outstanding common stock at a ratio between 1-for-5 and 1-for-100, to be implemented at the Board’s discretion within the next year, introducing the possibility of impactful changes to share count and trading price structure.
Insights
Nocera gained wide approval for major dilution-enabling actions.
The meeting shows strong participation, with 12,552,055 shares represented out of 14,373,597 outstanding as of the October 29, 2025 record date. All proposals passed with near-unanimous support, including director elections and auditor ratification, indicating broad alignment between management and voting stockholders in this context.
More importantly for capital structure, stockholders approved potential issuances of common stock above 19.99% of outstanding shares upon conversion of Series B Convertible Non-Voting Preferred Stock and senior secured convertible notes under a Securities Purchase Agreement dated October 31, 2025, even at prices below the Nasdaq Minimum Price. These approvals satisfy Nasdaq Listing Rule 5635(d) requirements and permit substantial future share issuance tied to those instruments.
Stockholders also authorized a reverse stock split in a range from 1-for-5 to 1-for-100, at the Board’s discretion within the next year, and increased authorized common shares from 200,000,000 to 2,000,000,000. Together, the large increase in authorized shares, reverse-split flexibility, and approved conversion-related issuances create scope for significant changes in share count and trading price mechanics, with actual impact depending on future Board decisions and conversions.